Amigo.

Healthcare in the United States rarely fails for lack of ambition. It fails for lack of hours. There are more patients who need intake, triage, reminders, follow-up and answers than there are clinicians with time to give them. Amigo, a New York company founded in 2023, is building software to absorb that overflow - not with a chatbot bolted onto a website, but with AI agents trained to work inside real clinical operations.

The company builds a platform that lets healthcare organizations design, train, deploy and manage patient-facing agents. Those agents handle intake and triage, care navigation, and around-the-clock patient support, and they plug into the electronic health records that hospitals already run on - Epic, Oracle Health and Athenahealth among them.

The name is not accidental. Amigo means friend, and the agents speak more than 100 languages - a practical answer to the fact that navigating care is hardest for the people least equipped to fight through it.

That framing is personal for co-founder and CEO Ali Khokhar. He was eight when his mother was diagnosed with breast cancer, and he watched his family struggle with the logistics of her care before she died when he was fourteen. Amigo is, in part, the tool he wishes his family had had.

What sets Amigo apart from the crowded field of healthcare AI is less the model than the training regimen. Before an agent ever speaks to a real patient, it completes what the company calls a digital residency: it practices across millions of simulated patient scenarios built around a specific practice's actual population.

Those simulations include virtual patient personas, edge cases and supervised evaluations. Amigo says an agent must reach a 100% safety pass rate in testing before it is allowed into production. The company reports zero safety incidents across more than three million real encounters.

A second, quieter layer sits underneath: a data foundation that ingests messy, unreliable healthcare data from every source, cleans and unifies it, and feeds the agent engine, EHR connectors and analytics. Fix the foundation first, then automate on top of it.

Amigo sells to healthcare organizations - digital-health companies, clinics and health systems. Publicly referenced customers include Eucalyptus, Hazel Health, Wisp, Jasper Health, Diverge Health and The Care Clinic, among more than 30 organizations, with Stanford Health Care named in its orbit through advisory ties.

The market it plays in - clinical AI agents and patient engagement - is competitive, with players such as Hippocratic AI and Infinitus pursuing overlapping ground. Amigo's differentiator is not that it deploys agents but the discipline it puts in front of deployment: simulation, supervised evaluation, and a refusal to ship below a safety bar.

The business model

Amigo runs a B2B SaaS model with two revenue streams: a monthly platform fee covering agent engineering, deployment strategy and training infrastructure, plus usage-based fees as agents handle patient interactions. The more work the agents do, the more the model scales - which is why the safety regimen matters commercially as well as clinically.